The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors
- 28 May 2010
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 321 (1), 20-28
- https://doi.org/10.1016/j.mce.2009.10.016
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Pten in stromal fibroblasts suppresses mammary epithelial tumoursNature, 2009
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancerCellular Signalling, 2009
- Should individual PI3 kinase isoforms be targeted in cancer?Current Opinion in Cell Biology, 2009
- Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid NeoplasiaEndocrinology and Metabolism Clinics of North America, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Thyroid carcinoma: molecular pathways and therapeutic targetsLaboratory Investigation, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt PathwayJournal of the American College of Surgeons, 2007
- Identification of a tumour suppressor network opposing nuclear Akt functionNature, 2006